Similar to the results of the CCK-8 assay, the PI3K agonist reversed the effects of the XCH decoction on breast cancer cells and the inhibition of the PI3K/Akt pathway (Figure 7C, 7D and Supplementary Figure 3). This evidence concerns the gene AKT1 and breast carcinoma.